Le Lézard
Classified in: Health, Science and technology
Subject: Product/Service

Riffyn Hits Enterprise-grade Compliance and Security Milestones

Riffyn, a global provider of cloud software for scientific process design and data analytics, announced today it has achieved two major compliance-related milestones:

Both accomplishments position Riffyn for routine use in the most demanding high-security and FDA-regulated environments at global enterprises.

"Providing secure, compliant, and uninterrupted business processes for our customers remains our top priority," said Timothy Gardner, CEO and President. "By meeting the highest security standards and regulatory obligations, we help our customers by reducing the barriers to innovation, simplifying the IT landscape, and reducing the costs associated with data integrity and information security."

ISO27001:2013 is one of the most widely recognized and internationally accepted information security standards. To achieve the certification, Riffyn's security compliance was validated by NQA after rigorously demonstrating a systematic and ongoing approach to managing and protecting company and customer data.

Riffyn also announced that it has been validated for GLP/GMP compliant use by a top-10 pharmaceutical company. In doing so, Riffyn demonstrates that it supports the highest quality guidelines for software development, documentation and testing.

"We are extremely proud that we have been recognized and validated for our adherence to FDA and ISO standards," said Gardner. "Riffyn is honored to partner with global leaders and support their goals of inventing medicines, materials, and sustainable biotechnology products for the most challenging needs."

About Riffyn (www.riffyn.com)

Riffyn's pioneering software-as-a-service platform for scientific experimentation solves previously intractable data fragmentation and data sharing problems in R&D organizations. Using patented technology based on "scientific blueprints", Riffyn breaks down data silos to provide deeply integrated data sets for real-time analysis and global access. Riffyn supports eight of the top 15 global biopharmaceutical, biotechnology, and food technology firms.

These press releases may also interest you

at 11:00
Hauseit, NYC's largest and most trusted For Sale by Owner and Buyer Closing Credit company, today announced the release of its industry leading New Development Buyer Closing Cost Calculator for NYC available at...

at 11:00
Full collection of event photos can be downloaded by clicking here. Spanish translation of the video can be viewed by clicking here. RapidVisa, the industry pioneer in online visa processing, celebrated its 10th anniversary and the grand opening of a...

at 10:45
TopConsumerReviews.com recently gave its best-in-class 5 star rating to Limos, a leader among Limo Services. The reasons for riding a limousine are endless. Whether it's just a trip from the airport, or fancy transportation to a girls' night or Prom,...

at 10:44
The best businesses in 33 European countries have been recognised in a 'Ones to Watch' list of business excellence published today by the European Business Awards, one of the world's largest and longest running cross sector businesses competitions....

at 10:36
According to Coherent Market Insights, the global testing, inspection, and certification (TIC) market is projected to exhibit a CAGR of 5.9% over the forecast period (2019 ? 2027). Market growth opportunities in the Global Testing, Inspection, and...

at 10:35
High incidence of chronic diseases globally and the need for personalized medicine, has encouraged several technological advancements in the form of recombinant DNA that involves genetic combinations of species to treat diseases. The recombinant DNA...

News published on 27 june 2019 at 09:05 and distributed by: